25 XP   0   0   10

Evotec SE ADR
Buy, Hold or Sell?

Let's analyse Evotec together

PenkeI guess you are interested in Evotec SE ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Evotec SE ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Evotec SE ADR

I send you an email if I find something interesting about Evotec SE ADR.

Quick analysis of Evotec (30 sec.)










What can you expect buying and holding a share of Evotec? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
$3.59
Expected worth in 1 year
$1.28
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
$-2.30
Return On Investment
-45.1%

For what price can you sell your share?

Current Price per Share
$5.10
Expected price per share
$0 - $7.96
How sure are you?
50%

1. Valuation of Evotec (5 min.)




Live pricePrice per Share (EOD)

$5.10

Intrinsic Value Per Share

$0.01 - $1.25

Total Value Per Share

$3.59 - $4.83

2. Growth of Evotec (5 min.)




Is Evotec growing?

Current yearPrevious yearGrowGrow %
How rich?$1.2b$1.4b-$203.8m-16.0%

How much money is Evotec making?

Current yearPrevious yearGrowGrow %
Making money-$175.6m$215.5m-$391.1m-222.7%
Net Profit Margin-23.4%34.9%--

How much money comes from the company's main activities?

3. Financial Health of Evotec (5 min.)




What can you expect buying and holding a share of Evotec? (5 min.)

Welcome investor! Evotec's management wants to use your money to grow the business. In return you get a share of Evotec.

What can you expect buying and holding a share of Evotec?

First you should know what it really means to hold a share of Evotec. And how you can make/lose money.

Speculation

The Price per Share of Evotec is $5.1. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Evotec.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Evotec, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.59. Based on the TTM, the Book Value Change Per Share is $-0.58 per quarter. Based on the YOY, the Book Value Change Per Share is $1.98 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Evotec.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.50-9.7%-0.50-9.7%0.6111.9%0.101.9%0.061.1%
Usd Book Value Change Per Share-0.58-11.3%-0.58-11.3%1.9838.8%0.5210.1%0.316.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.58-11.3%-0.58-11.3%1.9838.8%0.5210.1%0.316.2%
Usd Price Per Share8.09-8.09-23.75-39.29-27.19-
Price to Earnings Ratio-16.32--16.32-39.05-965.74-512.50-
Price-to-Total Gains Ratio-14.06--14.06-12.01-112.96-403.19-
Price to Book Ratio2.26-2.26-5.71-21.66-21.96-
Price-to-Total Gains Ratio-14.06--14.06-12.01-112.96-403.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.1
Number of shares196
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.580.52
Usd Total Gains Per Share-0.580.52
Gains per Quarter (196 shares)-112.76101.27
Gains per Year (196 shares)-451.05405.08
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-451-4610405395
20-902-9120810800
30-1353-1363012151205
40-1804-1814016201610
50-2255-2265020252015
60-2706-2716024302420
70-3157-3167028362825
80-3608-3618032413230
90-4059-4069036463635
100-4510-4520040514040

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%7.03.00.070.0%10.010.00.050.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%15.05.00.075.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%5.00.05.050.0%9.00.011.045.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%16.04.00.080.0%

Fundamentals of Evotec

About Evotec SE ADR

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals, as well as a strategic partnership with Dewpoint Therapeutics to advance oncology pipeline programs of condensate modifying therapeutics to investigational new drug applications and a licensing agreement with Glycotope GmbH to develop next generation immune cell engaging bispecifics for various potential indications, including solid tumors The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Fundamental data was last updated by Penke on 2024-04-11 08:33:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Evotec SE ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Evotec earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Evotec to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -23.4% means that $-0.23 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Evotec SE ADR:

  • The MRQ is -23.4%. The company is making a huge loss. -2
  • The TTM is -23.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-23.4%TTM-23.4%0.0%
TTM-23.4%YOY34.9%-58.2%
TTM-23.4%5Y8.7%-32.1%
5Y8.7%10Y4.5%+4.2%
1.1.2. Return on Assets

Shows how efficient Evotec is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Evotec to the Drug Manufacturers - Specialty & Generic industry mean.
  • -7.3% Return on Assets means that Evotec generated $-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Evotec SE ADR:

  • The MRQ is -7.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.3%TTM-7.3%0.0%
TTM-7.3%YOY9.0%-16.3%
TTM-7.3%5Y3.1%-10.3%
5Y3.1%10Y1.8%+1.3%
1.1.3. Return on Equity

Shows how efficient Evotec is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Evotec to the Drug Manufacturers - Specialty & Generic industry mean.
  • -13.8% Return on Equity means Evotec generated $-0.14 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Evotec SE ADR:

  • The MRQ is -13.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.8%TTM-13.8%0.0%
TTM-13.8%YOY14.6%-28.4%
TTM-13.8%5Y5.5%-19.3%
5Y5.5%10Y3.6%+1.9%

1.2. Operating Efficiency of Evotec SE ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Evotec is operating .

  • Measures how much profit Evotec makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Evotec to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 1.7% means the company generated $0.02  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Evotec SE ADR:

  • The MRQ is 1.7%. The company is operating less efficient.
  • The TTM is 1.7%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ1.7%TTM1.7%0.0%
TTM1.7%YOY4.4%-2.8%
TTM1.7%5Y9.3%-7.7%
5Y9.3%10Y9.1%+0.3%
1.2.2. Operating Ratio

Measures how efficient Evotec is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.97 means that the operating costs are $0.97 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Evotec SE ADR:

  • The MRQ is 0.972. The company is less efficient in keeping operating costs low.
  • The TTM is 0.972. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.972TTM0.9720.000
TTM0.972YOY0.933+0.040
TTM0.9725Y0.893+0.079
5Y0.89310Y0.904-0.011

1.3. Liquidity of Evotec SE ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Evotec is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.18 means the company has $3.18 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Evotec SE ADR:

  • The MRQ is 3.179. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.179. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.179TTM3.1790.000
TTM3.179YOY3.393-0.213
TTM3.1795Y2.726+0.454
5Y2.72610Y2.656+0.069
1.3.2. Quick Ratio

Measures if Evotec is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Evotec to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.85 means the company can pay off $3.85 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Evotec SE ADR:

  • The MRQ is 3.854. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.854. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.854TTM3.8540.000
TTM3.854YOY3.681+0.173
TTM3.8545Y2.996+0.858
5Y2.99610Y3.198-0.202

1.4. Solvency of Evotec SE ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Evotec assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Evotec to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.47 means that Evotec assets are financed with 47.4% credit (debt) and the remaining percentage (100% - 47.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Evotec SE ADR:

  • The MRQ is 0.474. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.474. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.474TTM0.4740.000
TTM0.474YOY0.384+0.090
TTM0.4745Y0.482-0.008
5Y0.48210Y0.425+0.057
1.4.2. Debt to Equity Ratio

Measures if Evotec is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Evotec to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 90.1% means that company has $0.90 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Evotec SE ADR:

  • The MRQ is 0.901. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.901. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.901TTM0.9010.000
TTM0.901YOY0.622+0.279
TTM0.9015Y0.968-0.067
5Y0.96810Y0.790+0.179

2. Market Valuation of Evotec SE ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Evotec generates.

  • Above 15 is considered overpriced but always compare Evotec to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -16.32 means the investor is paying $-16.32 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Evotec SE ADR:

  • The EOD is -10.289. Based on the earnings, the company is expensive. -2
  • The MRQ is -16.321. Based on the earnings, the company is expensive. -2
  • The TTM is -16.321. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.289MRQ-16.321+6.032
MRQ-16.321TTM-16.3210.000
TTM-16.321YOY39.053-55.374
TTM-16.3215Y965.736-982.057
5Y965.73610Y512.504+453.233
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Evotec SE ADR:

  • The EOD is 83.086. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 131.798. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 131.798. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD83.086MRQ131.798-48.711
MRQ131.798TTM131.7980.000
TTM131.798YOY2,555.043-2,423.245
TTM131.7985Y816.962-685.165
5Y816.96210Y535.614+281.348
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Evotec is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Evotec SE ADR:

  • The EOD is 1.422. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.256. Based on the equity, the company is underpriced. +1
  • The TTM is 2.256. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.422MRQ2.256-0.834
MRQ2.256TTM2.2560.000
TTM2.256YOY5.708-3.452
TTM2.2565Y21.661-19.404
5Y21.66110Y21.957-0.296
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Evotec SE ADR.

3.1. Institutions holding Evotec SE ADR

Institutions are holding 1.61% of the shares of Evotec SE ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Mubadala Investment Company PJSC1.29740.1827459770145977010
2023-12-31Federated Hermes Inc0.16280.0167576933-1600-0.2766
2023-12-31Zurcher Kantonalbank0.04920.0078174266-28102-13.8866
2023-12-31Millennium Management LLC0.02440.000486385-144677-62.6139
2023-12-31Optiver Holding B.V.0.02280.00068081069936643.1488
2023-12-31DCF Advisers, LLC0.01350.304347797-1250-2.5486
2023-12-31Morgan Stanley - Brokerage Accounts0.01230.000143707-24401-35.8269
2023-09-30Citadel Advisors Llc0.00730.0001257541225490.7704
2023-12-31Cetera Investment Advisers0.00720.00242563800
2023-12-31BlackRock Inc0.0034012178262227.4383
2023-12-31OLD MISSION CAPITAL LLC0.00340.002612019120190
2023-12-31Bank of America Corp0.0016057164729.0008
2023-12-31FMR Inc0.000802990-1496-33.3482
2023-12-31UBS Group AG0.00060227443523.6542
2023-12-31Quadrant Capital Group LLC0.00060.0022213021300
2023-12-31U.S. Bancorp0.000301220970388
2023-12-31SignatureFD, LLC0.00030.000399445283.3948
2023-12-31HHM Wealth Advisors, LLC0.00010.00094504500
2023-12-31GAMMA Investing LLC0.00010.00062852850
2023-12-31First Manhattan Co. LLC0.000102252250
Total 1.60820.52175699472+4498425+78.9%

3.2. Funds holding Evotec SE ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Federated Hermes Kaufmann Small Cap Grow0.16280.1604576933-1600-0.2766
2023-12-31Federated Hermes Kaufmann Small Cap A0.16280.1604576933-1600-0.2766
2023-11-30SWC (LU) EF Sustainable AA0.02980.0615105486-165-0.1562
2023-11-30SWC (LU) PF Sust Balanced (EUR) AA0.010.014535401-12444-26.009
2023-11-30SWC (CH) EF Sustainable Intl DT CHF0.00940.037833161-9-0.0271
2024-03-28ActivePassive International Equity ETF0.00540.0531190751410.7447
2024-02-29Fidelity Nasdaq Composite Index0.00240.0004850700
2024-03-31Comerica Foreign Equity CIT - Inst Class0.00130.0142466000
2023-12-31Morgan Stanley Vitality Portfolio R60.0011.8638348100
2023-12-31Franklin International Growth Equity ADR0.00024.1061570356.5421
2024-03-29Dimensional International Sstby Cr 1 ETF00.000315700
2023-12-31Fidelity Inst TM TPI Developed ex-US00.02611400
2024-03-31Morningstar Global Markets ADR00.0357900
Total 0.38516.53421364487-15642-1.1%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Evotec SE ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.575-0.5750%1.978-129%0.517-211%0.312-284%
Book Value Per Share--3.5853.5850%4.161-14%2.531+42%1.582+127%
Current Ratio--3.1793.1790%3.393-6%2.726+17%2.656+20%
Debt To Asset Ratio--0.4740.4740%0.384+24%0.482-2%0.425+12%
Debt To Equity Ratio--0.9010.9010%0.622+45%0.968-7%0.790+14%
Dividend Per Share----0%-0%-0%0.002-100%
Eps---0.496-0.4960%0.608-182%0.095-622%0.057-963%
Free Cash Flow Per Share--0.0610.0610%0.009+560%0.062-1%0.044+39%
Free Cash Flow To Equity Per Share---0.087-0.0870%1.134-108%0.471-118%0.322-127%
Gross Profit Margin--1.0771.0770%0.956+13%0.704+53%0.852+26%
Intrinsic Value_10Y_max--1.248--------
Intrinsic Value_10Y_min--0.005--------
Intrinsic Value_1Y_max--0.076--------
Intrinsic Value_1Y_min---0.021--------
Intrinsic Value_3Y_max--0.265--------
Intrinsic Value_3Y_min---0.044--------
Intrinsic Value_5Y_max--0.499--------
Intrinsic Value_5Y_min---0.048--------
Market Cap1807292140.800-59%2866861454.7202866861454.7200%8416311440.000-66%13923945646.336-79%9636059993.246-70%
Net Profit Margin---0.234-0.2340%0.349-167%0.087-367%0.045-615%
Operating Margin--0.0170.0170%0.044-62%0.093-82%0.091-82%
Operating Ratio--0.9720.9720%0.933+4%0.893+9%0.904+8%
Pb Ratio1.422-59%2.2562.2560%5.708-60%21.661-90%21.957-90%
Pe Ratio-10.289+37%-16.321-16.3210%39.053-142%965.736-102%512.504-103%
Price Per Share5.100-59%8.0908.0900%23.750-66%39.292-79%27.192-70%
Price To Free Cash Flow Ratio83.086-59%131.798131.7980%2555.043-95%816.962-84%535.614-75%
Price To Total Gains Ratio-8.865+37%-14.062-14.0620%12.009-217%112.958-112%403.190-103%
Quick Ratio--3.8543.8540%3.681+5%2.996+29%3.198+21%
Return On Assets---0.073-0.0730%0.090-181%0.031-337%0.018-503%
Return On Equity---0.138-0.1380%0.146-195%0.055-350%0.036-486%
Total Gains Per Share---0.575-0.5750%1.978-129%0.517-211%0.314-283%
Usd Book Value--1270524316.8001270524316.8000%1474398487.000-14%896747120.960+42%560758152.020+127%
Usd Book Value Change Per Share---0.575-0.5750%1.978-129%0.517-211%0.312-284%
Usd Book Value Per Share--3.5853.5850%4.161-14%2.531+42%1.582+127%
Usd Dividend Per Share----0%-0%-0%0.002-100%
Usd Eps---0.496-0.4960%0.608-182%0.095-622%0.057-963%
Usd Free Cash Flow--21752000.00021752000.0000%3294000.000+560%21875800.000-1%15637400.000+39%
Usd Free Cash Flow Per Share--0.0610.0610%0.009+560%0.062-1%0.044+39%
Usd Free Cash Flow To Equity Per Share---0.087-0.0870%1.134-108%0.471-118%0.322-127%
Usd Market Cap1807292140.800-59%2866861454.7202866861454.7200%8416311440.000-66%13923945646.336-79%9636059993.246-70%
Usd Price Per Share5.100-59%8.0908.0900%23.750-66%39.292-79%27.192-70%
Usd Profit---175655000.000-175655000.0000%215510000.000-182%33675400.000-622%20426900.000-960%
Usd Revenue--751448000.000751448000.0000%618034000.000+22%538449600.000+40%341749600.000+120%
Usd Total Gains Per Share---0.575-0.5750%1.978-129%0.517-211%0.314-283%
 EOD+4 -4MRQTTM+0 -0YOY+10 -245Y+13 -2110Y+14 -22

4.2. Fundamental Score

Let's check the fundamental score of Evotec SE ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.289
Price to Book Ratio (EOD)Between0-11.422
Net Profit Margin (MRQ)Greater than0-0.234
Operating Margin (MRQ)Greater than00.017
Quick Ratio (MRQ)Greater than13.854
Current Ratio (MRQ)Greater than13.179
Debt to Asset Ratio (MRQ)Less than10.474
Debt to Equity Ratio (MRQ)Less than10.901
Return on Equity (MRQ)Greater than0.15-0.138
Return on Assets (MRQ)Greater than0.05-0.073
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Evotec SE ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.123
Ma 20Greater thanMa 507.215
Ma 50Greater thanMa 1007.277
Ma 100Greater thanMa 2008.322
OpenGreater thanClose5.110
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Income before Tax  71,999-15,43756,562-30,75525,807211,173236,980-390,937-153,957
Net Income  84,172-46,10038,072-31,7946,278209,232215,510-391,165-175,655
Net Income from Continuing Operations  84,056-46,82837,228-30,9766,252209,258215,510-391,165-175,655



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets2,257,247
Total Liabilities1,070,063
Total Stockholder Equity1,187,184
 As reported
Total Liabilities 1,070,063
Total Stockholder Equity+ 1,187,184
Total Assets = 2,257,247

Assets

Total Assets2,257,247
Total Current Assets1,073,671
Long-term Assets1,183,576
Total Current Assets
Cash And Cash Equivalents 415,155
Short-term Investments 314,828
Net Receivables 256,737
Inventory 29,825
Other Current Assets 40,178
Total Current Assets  (as reported)1,073,671
Total Current Assets  (calculated)1,056,723
+/- 16,948
Long-term Assets
Property Plant Equipment 650,201
Goodwill 274,819
Long Term Investments 150,332
Intangible Assets 23,819
Long-term Assets Other 74,078
Long-term Assets  (as reported)1,183,576
Long-term Assets  (calculated)1,173,249
+/- 10,327

Liabilities & Shareholders' Equity

Total Current Liabilities337,706
Long-term Liabilities732,357
Total Stockholder Equity1,187,184
Total Current Liabilities
Short-term Debt 16,381
Short Long Term Debt 1,556
Accounts payable 97,277
Other Current Liabilities 87,378
Total Current Liabilities  (as reported)337,706
Total Current Liabilities  (calculated)202,592
+/- 135,114
Long-term Liabilities
Long term Debt 328,295
Capital Lease Obligations 176,823
Long-term Liabilities Other 977
Long-term Liabilities  (as reported)732,357
Long-term Liabilities  (calculated)506,095
+/- 226,262
Total Stockholder Equity
Common Stock176,953
Retained Earnings -392,377
Accumulated Other Comprehensive Income -37,402
Other Stockholders Equity 1,440,010
Total Stockholder Equity (as reported)1,187,184
Total Stockholder Equity (calculated)1,187,184
+/-0
Other
Capital Stock176,953
Cash and Short Term Investments 729,983
Common Stock Shares Outstanding 176,674
Current Deferred Revenue136,670
Liabilities and Stockholders Equity 2,257,247
Net Debt 91,519
Net Invested Capital 1,517,035
Net Working Capital 735,965
Property Plant and Equipment Gross 920,810
Short Long Term Debt Total 506,674



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
> Total Assets 
36,205
18,703
41,727
70,909
186,111
205,526
207,878
182,900
146,599
191,859
218,213
225,427
227,380
224,600
288,538
351,366
667,268
771,883
1,180,912
1,462,895
2,235,161
2,257,247
2,257,2472,235,1611,462,8951,180,912771,883667,268351,366288,538224,600227,380225,427218,213191,859146,599182,900207,878205,526186,11170,90941,72718,70336,205
   > Total Current Assets 
0
0
34,740
65,499
81,973
113,819
111,841
93,078
68,957
86,692
83,333
88,104
122,526
125,300
166,940
169,235
180,252
249,769
469,530
658,844
1,100,940
1,073,671
1,073,6711,100,940658,844469,530249,769180,252169,235166,940125,300122,52688,10483,33386,69268,95793,078111,841113,81981,97365,49934,74000
       Cash And Cash Equivalents 
0
0
1,391
4,116
53,520
78,723
37,991
55,064
32,926
21,091
17,777
39,065
45,644
48,710
44,497
83,940
67,017
109,055
277,034
422,164
699,326
415,155
415,155699,326422,164277,034109,05567,01783,94044,49748,71045,64439,06517,77721,09132,92655,06437,99178,72353,5204,1161,39100
       Short-term Investments 
0
0
31,511
60,032
93,499
20,527
58,136
29,034
25,432
47,445
46,006
26,572
52,494
41,206
90,461
43,922
34,558
40,824
44,628
70,054
159,172
314,828
314,828159,17270,05444,62840,82434,55843,92290,46141,20652,49426,57246,00647,44525,43229,03458,13620,52793,49960,03231,51100
       Net Receivables 
0
0
0
0
93,499
20,527
3,761
3,904
4,857
12,438
15,932
15,533
18,210
26,146
22,190
29,828
53,016
74,772
124,131
136,878
176,754
256,737
256,737176,754136,878124,13174,77253,01629,82822,19026,14618,21015,53315,93212,4384,8573,9043,76120,52793,4990000
       Other Current Assets 
0
0
1,837
496
-75,548
9,787
13,320
951
1,428
12,438
62
1,162
586
1,834
3,391
2,679
8,044
11,007
3,822
6,489
20,685
40,178
40,17820,6856,4893,82211,0078,0442,6793,3911,8345861,1626212,4381,42895113,3209,787-75,5484961,83700
   > Long-term Assets 
0
0
6,987
5,411
104,138
91,707
96,037
89,822
77,642
105,167
134,880
137,323
104,854
99,300
121,598
182,131
487,016
522,114
711,382
804,051
1,134,221
1,183,576
1,183,5761,134,221804,051711,382522,114487,016182,131121,59899,300104,854137,323134,880105,16777,64289,82296,03791,707104,1385,4116,98700
       Property Plant Equipment 
0
0
4,462
4,442
38,163
34,669
18,458
18,468
19,162
18,487
24,946
27,181
24,239
24,045
38,334
43,421
74,662
90,519
239,229
337,297
484,597
650,201
650,201484,597337,297239,22990,51974,66243,42138,33424,04524,23927,18124,94618,48719,16218,46818,45834,66938,1634,4424,46200
       Goodwill 
0
0
0
0
0
48,915
39,040
13,288
16,557
25,979
42,202
42,342
40,136
44,815
45,648
93,227
220,178
220,791
255,919
247,370
257,569
274,819
274,819257,569247,370255,919220,791220,17893,22745,64844,81540,13642,34242,20225,97916,55713,28839,04048,91500000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,990
41,252
59,021
287,009
150,332
150,332287,00959,02141,25228,99000000000000000000
       Intangible Assets 
0
0
0
0
0
42,989
37,480
47,167
29,010
57,615
67,652
63,266
39,826
30,210
25,154
22,454
135,033
122,989
116,994
98,036
30,851
23,819
23,81930,85198,036116,994122,989135,03322,45425,15430,21039,82663,26667,65257,61529,01047,16737,48042,98900000
       Other Assets 
0
24,650
6,987
5,411
0
0
0
0
0
0
0
0
0
66,792
66,277
66,728
66,887
58,825
57,988
62,327
79,343
0
079,34362,32757,98858,82566,88766,72866,27766,7920000000005,4116,98724,6500
> Total Liabilities 
0
0
5,697
9,183
37,442
68,350
37,325
33,041
35,112
59,222
70,968
72,880
68,413
66,217
101,444
137,430
335,521
347,003
703,883
740,049
857,476
1,070,063
1,070,063857,476740,049703,883347,003335,521137,430101,44466,21768,41372,88070,96859,22235,11233,04137,32568,35037,4429,1835,69700
   > Total Current Liabilities 
0
0
5,154
7,605
29,672
55,475
24,337
21,826
26,445
32,802
42,833
33,882
38,953
33,068
56,400
73,390
245,775
196,275
178,955
208,459
324,516
337,706
337,706324,516208,459178,955196,275245,77573,39056,40033,06838,95333,88242,83332,80226,44521,82624,33755,47529,6727,6055,15400
       Short-term Debt 
0
0
1,252
1,048
7,744
3,783
1,836
2,935
9,316
9,297
14,353
13,224
17,227
13,363
14,213
21,603
168,468
56,919
20,731
30,008
50,609
16,381
16,38150,60930,00820,73156,919168,46821,60314,21313,36317,22713,22414,3539,2979,3162,9351,8363,7837,7441,0481,25200
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
167,763
55,069
6,343
15,392
36,136
1,556
1,55636,13615,3926,34355,069167,7630000000000000000
       Accounts payable 
0
0
544
1,255
8,105
11,480
14,655
7,191
5,235
6,980
10,134
6,363
6,653
9,450
12,171
11,997
26,078
31,137
31,319
42,549
72,598
97,277
97,27772,59842,54931,31931,13726,07811,99712,1719,4506,6536,36310,1346,9805,2357,19114,65511,4808,1051,25554400
       Other Current Liabilities 
0
0
3,358
1,936
6,328
27,528
6,705
10,462
6,411
8,850
152
8,515
8,790
6,907
21,156
23,883
32,235
47,032
53,500
65,253
74,530
87,378
87,37874,53065,25353,50047,03232,23523,88321,1566,9078,7908,5151528,8506,41110,4626,70527,5286,3281,9363,35800
   > Long-term Liabilities 
0
0
543
1,577
7,770
12,875
12,988
11,215
8,667
26,420
28,135
38,998
29,460
33,149
45,044
64,040
89,746
150,728
524,928
531,590
532,960
732,357
732,357532,960531,590524,928150,72889,74664,04045,04433,14929,46038,99828,13526,4208,66711,21512,98812,8757,7701,57754300
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
70,155
93,182
82,560
69,633
70,652
0
070,65269,63382,56093,18270,1550000000000000000
> Total Stockholder Equity
36,205
18,703
-62,373
61,062
148,669
137,182
170,553
149,859
110,874
132,161
147,245
152,547
158,967
158,383
185,502
213,035
330,755
424,004
477,029
722,846
1,377,685
1,187,184
1,187,1841,377,685722,846477,029424,004330,755213,035185,502158,383158,967152,547147,245132,161110,874149,859170,553137,182148,66961,062-62,37318,70336,205
   Retained Earnings -392,377-216,421-434,249-441,177-481,013-566,733-592,934-622,312-638,828-631,850-606,417-608,895-615,644-618,904-573,381-495,094-506,876-474,408-89,984-65,14300
   Accumulated Other Comprehensive Income -37,402-12,638-37,522-19,562-27,200-28,903-25,152-18,510-23,169-27,410-25,5010-26,679-27,47800000000
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue820,802
Cost of Revenue-600,962
Gross Profit219,840219,840
 
Operating Income (+$)
Gross Profit219,840
Operating Expense-212,983
Operating Income1,7266,857
 
Operating Expense (+$)
Research Development69,688
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense212,98369,688
 
Net Interest Income (+$)
Interest Income-
Interest Expense-10,836
Other Finance Cost-10,836
Net Interest Income-
 
Pretax Income (+$)
Operating Income1,726
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-74,09282,558
EBIT - interestExpense = -9,110
-74,091
-84,147
Interest Expense10,836
Earnings Before Interest and Taxes (EBIT)1,726-63,256
Earnings Before Interest and Taxes (EBITDA)-20,416
 
After tax Income (+$)
Income Before Tax-74,092
Tax Provision--
Net Income From Continuing Ops--74,092
Net Income-94,983
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses813,945
Total Other Income/Expenses Net-80,8320
 

Technical Analysis of Evotec
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Evotec. The general trend of Evotec is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Evotec's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Evotec SE ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.8339 < 6.89 < 7.96.

The bearish price targets are: .

Tweet this
Evotec SE ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Evotec SE ADR. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Evotec SE ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Evotec SE ADR. The current macd is -0.34720017.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Evotec price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Evotec. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Evotec price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Evotec SE ADR Daily Moving Average Convergence/Divergence (MACD) ChartEvotec SE ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Evotec SE ADR. The current adx is 20.58.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Evotec shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Evotec SE ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Evotec SE ADR. The current sar is 7.77.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Evotec SE ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Evotec SE ADR. The current rsi is 26.12. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Evotec SE ADR Daily Relative Strength Index (RSI) ChartEvotec SE ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Evotec SE ADR. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Evotec price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Evotec SE ADR Daily Stochastic Oscillator ChartEvotec SE ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Evotec SE ADR. The current cci is -311.37152923.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Evotec SE ADR Daily Commodity Channel Index (CCI) ChartEvotec SE ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Evotec SE ADR. The current cmo is -56.54504214.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Evotec SE ADR Daily Chande Momentum Oscillator (CMO) ChartEvotec SE ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Evotec SE ADR. The current willr is -92.60747934.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Evotec SE ADR Daily Williams %R ChartEvotec SE ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Evotec SE ADR.

Evotec SE ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Evotec SE ADR. The current atr is 0.43843351.

Evotec SE ADR Daily Average True Range (ATR) ChartEvotec SE ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Evotec SE ADR. The current obv is -4,490,489.

Evotec SE ADR Daily On-Balance Volume (OBV) ChartEvotec SE ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Evotec SE ADR. The current mfi is 14.09.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Evotec SE ADR Daily Money Flow Index (MFI) ChartEvotec SE ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Evotec SE ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Evotec SE ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Evotec SE ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.123
Ma 20Greater thanMa 507.215
Ma 50Greater thanMa 1007.277
Ma 100Greater thanMa 2008.322
OpenGreater thanClose5.110
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Evotec with someone you think should read this too:
  • Are you bullish or bearish on Evotec? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Evotec? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Evotec SE ADR

I send you an email if I find something interesting about Evotec SE ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Evotec SE ADR.

Receive notifications about Evotec SE ADR in your mailbox!